{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:26:57Z","timestamp":1793226417484,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG19991"],"award-info":[{"award-number":["IG19991"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG27307"],"award-info":[{"award-number":["IG27307"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["MSCA IEF-891550"],"award-info":[{"award-number":["MSCA IEF-891550"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In breast cancer, the inner mitochondrial membrane fusion protein Optic Atrophy 1 (OPA1) is upregulated and its inhibition reverses acquired chemoresistance. However, it remains unclear whether OPA1 inhibition also targets normal breast cells. We show that OPA1 upregulation is a hallmark of metastatic breast cancer cells, which are selectively susceptible to OPA1 inhibition compared to isogenic normal or localized tumor cells. In an isogenic model spanning normal, transformed, and metastatic breast cancer cells, levels of Mitofusin 1 (MFN1) progressively declined while dynamin related protein 1 (DRP1) became increasingly active, correlating with fragmented mitochondria during cancer progression. Meanwhile, OPA1 levels were elevated in invasive cells characterized by mitochondrial fragmentation, tight cristae, and high respiration. OPA1 deletion selectively reduced metastatic cells mitochondrial respiration, proliferation, and migration. Specific OPA1 inhibitors MYLS22 and Opitor-0 diminished migration and increased death of metastatic cells, underscoring OPA1 as a selective vulnerability of metastatic breast cancer.<\/jats:p>","DOI":"10.1038\/s41419-025-07878-5","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T04:58:29Z","timestamp":1753073909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Metastatic breast cancer cells are selectively dependent on the mitochondrial cristae-shaping protein OPA1"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-8937","authenticated-orcid":false,"given":"Antigoni","family":"Diokmetzidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8128-6462","authenticated-orcid":false,"given":"Aurora","family":"Maracani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-3493","authenticated-orcid":false,"given":"Anna","family":"Pellattiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Cardenas-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan A.","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8515-8928","authenticated-orcid":false,"given":"Luca","family":"Scorrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"7878_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","volume":"17","author":"RV Simoes","year":"2015","unstructured":"Simoes RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, et al. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia. 2015;17:671\u201384.","journal-title":"Neoplasia"},{"key":"7878_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","volume":"22","author":"F Dupuy","year":"2015","unstructured":"Dupuy F, Tabaries S, Andrzejewski S, Dong Z, Blagih J, Annis MG, et al. PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab. 2015;22:577\u201389.","journal-title":"Cell Metab"},{"key":"7878_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu VS, O\u2019Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014;16:992\u20131003.","journal-title":"Nat Cell Biol"},{"key":"7878_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41556-020-0477-0","volume":"22","author":"RT Davis","year":"2020","unstructured":"Davis RT, Blake K, Ma D, Gabra MBI, Hernandez GA, Phung AT, et al. Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing. Nat Cell Biol. 2020;22:310\u201320.","journal-title":"Nat Cell Biol"},{"key":"7878_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29:115\u201326.","journal-title":"Nat Med"},{"key":"7878_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","volume":"155","author":"S Cogliati","year":"2013","unstructured":"Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155:160\u201371.","journal-title":"Cell"},{"key":"7878_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcancer.2017.06.007","volume":"47","author":"L Simula","year":"2017","unstructured":"Simula L, Nazio F, Campello S. The mitochondrial dynamics in cancer and immune-surveillance. Semin Cancer Biol. 2017;47:29\u201342.","journal-title":"Semin Cancer Biol"},{"key":"7878_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12957-022-02799-5","volume":"20","author":"J Xing","year":"2022","unstructured":"Xing J, Qi L, Liu X, Shi G, Sun X, Yang Y. Roles of mitochondrial fusion and fission in breast cancer progression: a systematic review. World J Surg Oncol. 2022;20:331.","journal-title":"World J Surg Oncol"},{"key":"7878_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.cmet.2017.09.024","volume":"26","author":"HJ Weir","year":"2017","unstructured":"Weir HJ, Yao P, Huynh FK, Escoubas CC, Goncalves RL, Burkewitz K, et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab. 2017;26:884\u2013896.e885.","journal-title":"Cell Metab"},{"key":"7878_CR10","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2012.494","volume":"32","author":"J Zhao","year":"2013","unstructured":"Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene. 2013;32:4814\u201324.","journal-title":"Oncogene"},{"key":"7878_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s43018-023-00563-6","volume":"4","author":"PK Parida","year":"2023","unstructured":"Parida PK, Marquez-Palencia M, Ghosh S, Khandelwal N, Kim K, Nair V, et al. Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases. Nat Cancer. 2023;4:893\u2013907.","journal-title":"Nat Cancer"},{"key":"7878_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01301-x","volume":"22","author":"BA Humphries","year":"2020","unstructured":"Humphries BA, Cutter AC, Buschhaus JM, Chen YC, Qyli T, Palagama DSW, et al. Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer. Breast Cancer Res. 2020;22:60.","journal-title":"Breast Cancer Res"},{"key":"7878_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm8212","volume":"10","author":"L Minarrieta","year":"2024","unstructured":"Minarrieta L, Annis MG, Audet-Delage Y, Kuasne H, Pacis A, St-Louis C, et al. Mitochondrial elongation impairs breast cancer metastasis. Sci Adv. 2024;10:eadm8212.","journal-title":"Sci Adv"},{"key":"7878_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1083-y","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen L, Zhang J, Lyu Z, Chen Y, Ji X, Cao H, et al. Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells. Cell Death Dis. 2018;9:1050.","journal-title":"Cell Death Dis"},{"key":"7878_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","volume":"126","author":"C Frezza","year":"2006","unstructured":"Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177\u201389.","journal-title":"Cell"},{"key":"7878_CR16","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.7150\/jca.96100","volume":"15","author":"YT Tzeng","year":"2024","unstructured":"Tzeng YT, Chu PY, Yong SB, Hsu TS, Tseng LM, Hou MF, et al. Spatial and Single-cell investigations illuminate theragnostic value and immune landscape of mitochondrial dynamin-like GTPase in breast cancer. J Cancer. 2024;15:3633\u201344.","journal-title":"J Cancer"},{"key":"7878_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-022-02304-6","volume":"41","author":"M Zamberlan","year":"2022","unstructured":"Zamberlan M, Boeckx A, Muller F, Vinelli F, Ek O, Vianello C, et al. Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. J Exp Clin Cancer Res. 2022;41:95.","journal-title":"J Exp Clin Cancer Res"},{"key":"7878_CR18","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41388-023-02596-8","volume":"42","author":"ML Baek","year":"2023","unstructured":"Baek ML, Lee J, Pendleton KE, Berner MJ, Goff EB, Tan L, et al. Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment. Oncogene. 2023;42:1117\u201331.","journal-title":"Oncogene"},{"key":"7878_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cmet.2020.04.007","volume":"31","author":"S Herkenne","year":"2020","unstructured":"Herkenne S, Ek O, Zamberlan M, Pellattiero A, Chergova M, Chivite I, et al. Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1. Cell Metab. 2020;31:987\u20131003.e1008.","journal-title":"Cell Metab"},{"key":"7878_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau7314","volume":"5","author":"J Vande Voorde","year":"2019","unstructured":"Vande Voorde J, Ackermann T, Pfetzer N, Sumpton D, Mackay G, Kalna G, et al. Improving the metabolic fidelity of cancer models with a physiological cell culture medium. Sci Adv. 2019;5:eaau7314.","journal-title":"Sci Adv"},{"key":"7878_CR21","doi-asserted-by":"crossref","unstructured":"Pellattiero A, Quirin C, Magrin F, Sturlese M, Fracasso A, Biris N, et al. Small molecule OPA1 inhibitors amplify cytochrome c release and reverse cancer cells resistance to Bcl-2 inhibitors. Sci Adv. 2025;11:eadx4562.","DOI":"10.1126\/sciadv.adx4562"},{"key":"7878_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1241359","volume":"342","author":"A Kasahara","year":"2013","unstructured":"Kasahara A, Cipolat S, Chen Y, Dorn GW 2nd, Scorrano L. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science. 2013;342:734\u20137.","journal-title":"Science"},{"key":"7878_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"7878_CR24","first-page":"313","volume":"148","author":"PJ Dawson","year":"1996","unstructured":"Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol. 1996;148:313\u20139.","journal-title":"Am J Pathol"},{"key":"7878_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1006461422273","volume":"65","author":"SJ Santner","year":"2001","unstructured":"Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat. 2001;65:101\u201310.","journal-title":"Breast Cancer Res Treat"},{"key":"7878_CR26","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1074\/jbc.M607279200","volume":"282","author":"N Taguchi","year":"2007","unstructured":"Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem. 2007;282:11521\u20139.","journal-title":"J Biol Chem"},{"key":"7878_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1128\/MCB.01054-14","volume":"35","author":"T Ishihara","year":"2015","unstructured":"Ishihara T, Ban-Ishihara R, Maeda M, Matsunaga Y, Ichimura A, Kyogoku S, et al. Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development. Mol Cell Biol. 2015;35:211\u201323.","journal-title":"Mol Cell Biol"},{"key":"7878_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cell.2010.02.026","volume":"141","author":"H Chen","year":"2010","unstructured":"Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 2010;141:280\u20139.","journal-title":"Cell"},{"key":"7878_CR29","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, et al. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74:477\u201395.","journal-title":"CA Cancer J Clin"},{"key":"7878_CR30","doi-asserted-by":"publisher","first-page":"R618","DOI":"10.1016\/j.cub.2022.05.006","volume":"32","author":"L Alan","year":"2022","unstructured":"Alan L, Scorrano L. Shaping fuel utilization by mitochondria. Curr Biol. 2022;32:R618\u2013r623.","journal-title":"Curr Biol"},{"key":"7878_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.molcel.2015.01.002","volume":"57","author":"JA Kashatus","year":"2015","unstructured":"Kashatus JA, Nascimento A, Myers LJ, Sher A, Byrne FL, Hoehn KL, et al. Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Mol Cell. 2015;57:537\u201351.","journal-title":"Mol Cell"},{"key":"7878_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.molcel.2015.02.021","volume":"58","author":"A Pyakurel","year":"2015","unstructured":"Pyakurel A, Savoia C, Hess D, Scorrano L. Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. Mol Cell. 2015;58:244\u201354.","journal-title":"Mol Cell"},{"key":"7878_CR33","doi-asserted-by":"publisher","first-page":"15927","DOI":"10.1073\/pnas.0407043101","volume":"101","author":"S Cipolat","year":"2004","unstructured":"Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA. 2004;101:15927\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7878_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-43","volume":"12","author":"Y Chen","year":"2013","unstructured":"Chen Y, Song Y-X, Wang Z-N. The MicroRNA-148\/152 family: multi-faceted players. Mol Cancer. 2013;12:43.","journal-title":"Mol Cancer"},{"key":"7878_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05768-2","volume":"14","author":"M Noguchi","year":"2023","unstructured":"Noguchi M, Kohno S, Pellattiero A, Machida Y, Shibata K, Shintani N, et al. Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line. Cell Death Dis. 2023;14:241.","journal-title":"Cell Death Dis"},{"key":"7878_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Glytsou C, Zhou H, Narang S, Reyna DE, Lopez A, et al. Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment. Cancer Discov. 2019;9:890\u2013909.","journal-title":"Cancer Discov"},{"key":"7878_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41375-023-01835-x","volume":"37","author":"C Larrue","year":"2023","unstructured":"Larrue C, Mouche S, Lin S, Simonetta F, Scheidegger NK, Poulain L, et al. Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia. Leukemia. 2023;37:765\u201375.","journal-title":"Leukemia"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07878-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:09:20Z","timestamp":1757261360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07878-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7878"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07878-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LS and AP are inventors in the PCT\/EP2019\/068846 on MYLS22 and Opitor-0 as anticancer drugs. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations applicable in Italy. The research reported here does not include studies on vertebrates, or patients and did not require ethical committees approval nor informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"539"}}